GE HealthCare is said to near $1B Sofie Biosciences deal
FinkAvenue/iStock Editorial via Getty Images
GE HealthCare Technologies (GEHC) is in advanced talks to acquire Sofie Biosciences for about $1 billion, a move that would expand its presence in radioactive diagnostic agents used with medical scans, the Financial Times reported Sunday, citing people familiar with the matter.
KioskNews shows a cleaned-up reading view extracted from the publisher’s page — the original always lives on their site, not ours.